Dr. Centeno is the founder and chief medical officer for Regenexx. In 2005, Dr. Centeno opened the Centeno-Schultz Clinic, where he performed the first advanced, orthopedic stem cell procedure in the United States. With Dr. Centeno as medical director, The Centeno-Schultz Clinic remains an active teaching and research-based practice, with a state-of-the-art cell biology research lab, a bioengineering department, and a clinical research arm.
Dr. Centeno is one of the few physicians in the world with extensive experience in the culture expansion, and clinical use, of adult stem cells to treat orthopedic injuries. He is considered an expert in the field of regenerative medicine and interventional orthopedics, chairing multiple international lectures and conferences in the field. He has numerous publications listed in the U.S. National Library of Medicine and has also served as the editor-in-chief of a medical research journal dedicated to traumatic injury.
In addition to founding Regenexx and the Centeno-Schultz Clinic, Dr. Centeno is also a founding member of the International Cellular Medicine Society and the Spinal Injury Foundation.
Dr. Centeno enjoys writing and is the author of numerous books on orthopedics and regenerative medicine. He also maintains a daily blog to help patients navigate the latest regenerative medicine news and research. When he is not working, Dr. Centeno enjoys spending time with his family.
“Our website makes the bold claim that we invented orthopedic stem cell therapy. In fact, that’s true. I, and my partner, John Schultz, began using stem cells to treat orthopedic issues, like knee arthritis, shoulder rotator cuff tears, and low-back disc issues, back in 2005, before anyone else. It was years before there was even another provider interested. Hence, we’ve learned a lot about what works and what doesn’t.”
Centeno-Schultz Clinic - South Denver
If you are interested in booking a phone consultation with Dr. Centeno, please contact our patient care team at [email protected] or by calling 1-877-211-3834 (U.S. toll-free), 0-800-041-8772 (U.K. toll-free), or 1-345-943-5900 (Local).